Up Close

Alan Billingsley, San Francisco-based director for RREEF, talks with GlobeSt.com's Paul Bubny, about the outlook for rent growth in terms of geographic markets and specific sectors.

The acquisition of Gravitas was just the latest move in the bolstering of Studley’s services in what the firm says is a rapidly growing niche.

‘There’s new developments in Romania and Bulgaria. Poland, the Czech Republic and Hungary are recovering. Green shoots are coming up, as they say here,’ says Tishman International’s Alan Levy.

Colliers' executive vice president of the New Jersey region, Bob Martie, is bringing a consulting approach to the brokerage business.

'There is a dangerous sense in this country that we know everything about everything--and the more you talk to other parts of world you realize that is just not true,' says ULI's Peter Rummell.

'It's important for people to know that we speak on behalf of the entire state,' says NAIOP New Jersey's new president, George Sowa.

'Believe it or not, in New York and New Jersey, non-performing debt is trading at almost the same level as it would for an REO,' says Helios' Jonathan Horn.

'We're starting to see a slow, cautious optimism but with a very low interest rate from the Fed, banks are slowly writing down their distress on a quarter-by-quarter basis,' says CBC's Fred Schmidt

SANTA ANA, CA-The CEO of Grubb & Ellis Healthcare REIT II and Grubb & Ellis Equity Advisors talks about why healthcare is the company's most active investment sector these days.

“On the federal side it's kind of a wait-and-see.”

“There’s been positive trends – exports and manufacturing continue to show growth, railroad shipments show growth, and companies appear to show growth in income statements.”

'If you just take the banks and the CMBS markets, there is a tremendous amount of product available,' says the firm's vice chairman, Ed Indvik.

'The deals everyone is chasing are the distressed assets--how do I get the big value play?,' says Kaufman.

“There’s a number of people looking at new development opportunities, but the challenge remains cost,” Segal says.

There’s almost everything in New York City to support a commercial life science sector except lab space, Alexandria’s CEO tells GlobeSt.com.